Docohexaenoic acid for improved glycemic control

Details Docohexaenoic acid for improved glycemic control Docohexaenoic acid for improved glycemic control

A - Human Necessities

61

K

A61K 31/20 (2006.01)

Patent

CA 2499983

This invention is directed to methods of treating patients with metabolic syndrome, prediabetes and/or Type 11 diabetes mellitus by administering docosahexaenoic acid (DHA) alone or in combination with diabetes-related medications.

La présente invention concerne des procédés permettant de traiter les patients souffrant d'un syndrome métabolique, de prédiabète et/ou de diabète sucré de type II en leur administrant de l'acide docosahexaénoïque (DHA) seul ou combiné à des médicaments liés au diabète.

Affiliated with

Also associated with

Rating

Docohexaenoic acid for improved glycemic control does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Docohexaenoic acid for improved glycemic control, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Docohexaenoic acid for improved glycemic control will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1496087